Exact Sciences
$119.449876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$119.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.32 (+2.00%) Today
+$1.25 (+1.06%) As of 7:18 AM EST after-hours
Why Robinhood?
You can buy or sell Exact Sciences and other stocks, options, and ETFs commission-free!
About EXAS
Exact Sciences Corporation Common Stock, also called Exact Sciences, is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI. The listed name for EXAS is Exact Sciences Corporation Common Stock.
CEO
Kevin T. Conroy
Employees
4,110
Headquarters
Madison, Wisconsin
Founded
1995
Market Cap
18.80B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.46M
High Today
$121.06
Low Today
$116.00
Open Price
$117.32
Volume
1.07M
52 Week High
$141.90
52 Week Low
$35.25
Collections
Analyst Ratings
100%
of 15 ratings
Buy
100%
Hold
0%
Sell
0%
EXAS Earnings
-$0.66
-$0.44
-$0.22
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 9, Pre-Market